TY - JOUR AU - B. M. Alghamdi AU - S. Rogers AU - S. Roberman AU - M. Williamson AU - L. Panahi A1 - AB - OBJECTIVE: To assess the feasibility and impact of incorporating a multidisciplinary pharmacogenomics (PGx) service within an underserved behavioral health clinic, with an emphasis on clinician perceptions. METHODOLOGY: This study was conducted in two phases at the Texas A&M Family Care Clinic. Phase one involved an online cross-sectional survey of the multidisciplinary clinic team to assess their knowledge, attitudes, and readiness for PGx integration. Phase two detailed the development and implementation of a PGx service within the Integrated Behavioral Health (IBH) clinic, outlining the workflow and collaborative approach used to offer genetic testing to eligible patients. KEY FINDINGS: Of the 23 survey participants, 91% believed the PGx service would positively impact patient care, and 87% expressed interest in receiving PGx-related training. Confidence in pharmacists' ability to lead the service was reported by 65% of respondents. The primary concerns identified included cost of care, clinical utility, and potential workflow disruptions. A collaborative implementation model was developed, including preemptive and reactive testing pathways. CONCLUSION: The implementation of a pharmacist-driven PGx service in an underserved behavioral health clinic was well-received by the clinical team and deemed feasible. While concerns regarding resources and workflow were noted, strong interest in training and multidisciplinary collaboration highlights the potential for scalable PGx service models in similar settings. AD - Department of Clinical Pharmacy, Albaha College of Pharmacy, Albaha University, Al Bahah, Saudi Arabia.; Department of Pharmacy Practice, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Kingsville, TX, United States.; Department of Translational Medical Sciences, School of Medicine, Texas A&M Health Science Center, Bryan, TX, United States.; American Society of Pharmacovigilance, Houston, TX, United States.; Department of Primary Care and Rural Medicine, Texas A&M Health Science Center School of Medicine, Bryan, TX, United States. AN - 40487400 BT - Front Pharmacol C5 - Education & Workforce; Healthcare Disparities DO - 10.3389/fphar.2025.1594032 DP - NLM ET - 20250522 JF - Front Pharmacol LA - eng N2 - OBJECTIVE: To assess the feasibility and impact of incorporating a multidisciplinary pharmacogenomics (PGx) service within an underserved behavioral health clinic, with an emphasis on clinician perceptions. METHODOLOGY: This study was conducted in two phases at the Texas A&M Family Care Clinic. Phase one involved an online cross-sectional survey of the multidisciplinary clinic team to assess their knowledge, attitudes, and readiness for PGx integration. Phase two detailed the development and implementation of a PGx service within the Integrated Behavioral Health (IBH) clinic, outlining the workflow and collaborative approach used to offer genetic testing to eligible patients. KEY FINDINGS: Of the 23 survey participants, 91% believed the PGx service would positively impact patient care, and 87% expressed interest in receiving PGx-related training. Confidence in pharmacists' ability to lead the service was reported by 65% of respondents. The primary concerns identified included cost of care, clinical utility, and potential workflow disruptions. A collaborative implementation model was developed, including preemptive and reactive testing pathways. CONCLUSION: The implementation of a pharmacist-driven PGx service in an underserved behavioral health clinic was well-received by the clinical team and deemed feasible. While concerns regarding resources and workflow were noted, strong interest in training and multidisciplinary collaboration highlights the potential for scalable PGx service models in similar settings. PY - 2025 SN - 1663-9812 (Print); 1663-9812 SP - 1594032 ST - Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic T1 - Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic T2 - Front Pharmacol TI - Implementation and integration of a multidisciplinary pharmacogenomics service in an underserved integrated behavioral health clinic U1 - Education & Workforce; Healthcare Disparities U3 - 10.3389/fphar.2025.1594032 VL - 16 VO - 1663-9812 (Print); 1663-9812 Y1 - 2025 ER -